Howard Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.01M Buy
19,725
+10,127
+106% +$2.36M 0.06% 107
2026
Q1
$2.35M Sell
9,598
-9,305
-49% -$2.17M 0.04% 113
2025
Q4
$3.91M Buy
18,903
+100
+0.5% +$19.8K 0.05% 115
2025
Q3
$3.49M Buy
18,803
+600
+3% +$103K 0.05% 119
2025
Q2
$2.78M Buy
18,203
+1,693
+10% +$260K 0.04% 131
2025
Q1
$2.74M Sell
16,510
-2,369
-13% -$371K 0.07% 111
2024
Q4
$2.73M Buy
18,879
+1,029
+6% +$159K 0.04% 119
2024
Q3
$2.89M Buy
+17,850
New +$2.84M 0.05% 118
2023
Q3
Sell
-1,214
Closed -$201K 60
2023
Q2
$201K Buy
+1,214
New +$196K 0.03% 58
2023
Q1
Sell
-2,386
Closed -$421K 48
2022
Q4
$421K Buy
2,386
+138
+6% +$23.8K 0.12% 18
2022
Q3
$368K Sell
2,248
-229
-9% -$38.8K 0.11% 18
2022
Q2
$440K Buy
2,477
+64
+3% +$11.4K 0.12% 22
2022
Q1
$428K Buy
2,413
+145
+6% +$24.7K 0.1% 26
2021
Q4
$388K Buy
+2,268
New +$371K 0.05% 50

Other funds holding JNJ

Howard Capital Management's JNJ Position: Q2 2026 in Review

Howard Capital Management increased its Johnson & Johnson (JNJ) stake by 106% in Q2 2026, buying an estimated $2.36M and bringing the position to 19,725 shares worth $5.01M. The position accounts for 0.06% of the portfolio, ranked #107.

Howard Capital Management first reported a position in JNJ in Q4 2021 and has held it in 14 quarters since. 2,086 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Howard Capital Management held 19,725 shares of Johnson & Johnson worth $5.01M as of Q2 2026.
  • Howard Capital Management bought 10,127 Johnson & Johnson shares in Q2 2026, an estimated $2.36M.
  • Johnson & Johnson made up 0.06% of Howard Capital Management's portfolio in Q2 2026, its #107 holding.
  • Howard Capital Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 14 quarters since.
  • 2,086 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Howard Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.